|
Global sum concept "rotten to the core"
The global sum concept for funding National Health
Service pharmaceutical services is rotten to the core and utterly fails
to provide for the present or future funding, according to Sue Sharpe,
chief executive of the Pharmaceutical Services Negotiating Committee.
The new contract, which had been promised by the year's end, had to refund
actual NHS service costs and provide a reasonable return on investment.
Hard evidence of the current situation was needed and research would be
needed.
The new contract was just one of a range of pressures
faced by community pharmacists. Others were the introduction of local
pharmaceutical services, the delivery of new services, the threatened
Office of Fair Trading survey, and difficulties in funding the service.
To these had to be added the key planks of Governmental policy: clinical
governance and lifelong learning; structuring a service around patients;
breaking down professional barriers; and providing equity of care and
confounding social inequalities.
Into this complex picture had to be added the shortage
of pharmacists (and other health care professionals), under-investment
in the service and the recent series of high profile health care failures
(eg, Bristol). The result was a can of worms. Resolution was not an easy
task, but the situation was not impossible if one kept a positive outlook
and saw the difficulties as opportunities. The profession had to become
a body that influenced rather than responded, engaged locally with primary
care trusts, and developed alliances and partnerships.
Looking at services that might be developed. Mrs
Sharpe said that structured medicine usage had to remain a priority because
50 per cent of preparations were not used properly. The PSNC-devised pilots
of medicines management were to start soon.
Repeat dispensing could be developed using the concept
of a "master" prescription for, say, six month's supply, dispensed monthly.
But under current payment methods, the inevitable increase in prescription
numbers would further lower contractors' income per script. Hence the
new contract needed to address the increased responsibility of the pharmacist
and not just pay for a supply role.
Out-of-hours pharmaceutical services could be provided
by a deputising service, but the question of community pharmacist involvement
was as yet unresolved.
The notion of pharmacists prescribing non-prescription
medicines for patients on low incomes had been so successfully piloted
in the area, but was feared by Government as a huge lever to increase
costs.
Domiciliary visiting was desirable, but the pharmacist's
absence from the pharmacy negated a major strength of the profession
accessibility. A way forward was needed.
New roles for the PSNC itself included the development
of a quality framework for the new contract, the roll-out of new core
roles which had to be deliverable and not pie in the sky and finding
ways of halving the prevalence of medication errors.
On the funding of pharmaceutical services, Mrs Sharpe
said that, apart from replacing the global sum concept, the immediate
issues were payment for generics and control of entry.
Asked how a community pharmacist who joined a PCT
professional executive committee could take a full part in its meetings,
which were invariably held during working hours, Mrs Sharpe said that
there was no simple answer but one possibility was to negotiate protected
time, say by pharmacies not opening till 10.30am on one Wednesday a month.
|